Skip to main content

Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice

AAPS PharmSci volume 2, pages 109–116 (2000)Cite this article

Abstract

Drug treatment poses a therapeutic challenge in cystic fibrosis (CF) because the disposition of a number of drugs is altered in CF. Enhanced clearance of acetaminophen (APAP) and indocyanine green (ICG) have previously been reported in CF patients. The objective of the current study was to investigate if the CF-knockout mouse model (cftrm1UNC) shows altered pharmacokinetics similar to those seen in CF patients using the 2 model compounds APAP and ICG. Clearance (CL/F) of APAP and renal (CLR) and formation (CLf) clearance of acetaminophen glucuronide (AG) and acetaminophen sulfate (AS) were determined in CF-knockout mice following administration of APAP (50 mg/kg, intraperitoneal). CLR of AS was 19.5 and 12.9 (mL/min per kg) and CLf of AS was 10.4 and 6.7 mL/min per kg for homozygous and heterozygous males, respectively, which was significantly different between groups. CLR of AG was 6.3 and 4.8 mL/min per kg and CLf of AG was 9.6 and 8.9 mL/min per kg for homozygous and heterozygous males, respectively, although not reaching statistical significance. No significant differences were noted in either ClR or CLf of AG and AS in female CF mice. Plasma concentrations of ICG (10 mg/kg, intravenous) were determined over 0 to 15 minutes. Homozygous females showed a higher apparent volume of distribution (96 mL/kg) relative to heterozygous females (72 mL/kg). Similar to CF patients, a trend toward a lower Cmax was noted in homozygous male and female mice. However, contrary to human data, no significant differences in CL of ICG were noted. These results suggest that the CF-knockout mice have potential as a model for studying altered drug disposition in CF patients.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Welsh MJ, Smith AE. Cystic fibrosis. Scientific American. 1995;273:52–59.

    CAS  PubMed  Article  Google Scholar 

  2. Kearns GL, Mallory GB, Crom WR, Evans WE. Enhanced hepatic drug clearance in patients with cystic fibrosis. Pediatr Pharmacol Ther. 1990;117:972–979.

    CAS  Google Scholar 

  3. Kearns GL. Hepatic drug metabolism in cystic fibrosis: recent developments and future directions. Ann Pharmacother. 1993;27:74–79.

    CAS  PubMed  Google Scholar 

  4. Kearns GL, Crom WR, Karlson KH, Mallory GB, Evans WE. Hepatic drug clearance in patients with mild cystic fibrosis. Clin Pharmcol Ther. 1996;59:529–540.

    CAS  Article  Google Scholar 

  5. Hutabarat RM, Unadkat JD, Kushmerick P, Aitken ML, Slattery JT, Smith A. Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clin Pharmacol Ther. 1991;50:695–701.

    CAS  PubMed  Article  Google Scholar 

  6. Cressman VL, Hicks EM, Funkhouser WK, Backlund DC, Koller BH. The relationship of chronic mucin secretion to airway disease in normal and cftr-deficient mice. Am J Resp Cell Mol Biol. 1998;19:853–866.

    CAS  Article  Google Scholar 

  7. Snouwaert JN, Brigman KK, Latour et al. An animal model for cystic fibrosis made by gene targeting. Science. 1992;257:1083–1088.

    CAS  PubMed  Article  Google Scholar 

  8. Miller DA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  9. Wang LH, Rudolph AM, Benet LZ. Pharmacokinetic studies of the disposition of acetaminophen in the sheep maternal-placental-fetal unit. J Pharmacol Exp Ther. 1986;238:198–205.

    CAS  PubMed  Google Scholar 

  10. Heintz R, Svensson CK, Stoeckel K, Powers GJ, Lalka D. Indocyanine green: pharmacokinetics in the rabbit and relevant studies of its stability and purity. J Pharm Sci. 1986;75:398–402.

    CAS  PubMed  Article  Google Scholar 

  11. Ott P, Keiding S, Bass L. Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis. Hepatology. 1993;6:1504–1515.

    Google Scholar 

  12. Falls JG, Blake BL, Cao Y, Levi PE, Hodgson, E. Gender differences in hepatic expression of flavin-containing monooxygenase isoforms (FMO1, FMO3, and FM05) in mice. J Biochem Tox. 1995;10:171–177.

    CAS  Article  Google Scholar 

  13. Rao UN, Aravindakshan M, Satyanarayan V, Chauhan PS. Genotype-and gender-dependent hepatic alcohol dehydrogenase (ADH) activity in developing mice. http://www.ncbi.nlm.nih.gov/htbin-post/PubMed/wgetcit?journal=Alcohol&volume=14&page=527&display=abstract&format=htmlAlcohol. 1997;14:527–531.

    CAS  Google Scholar 

  14. Kane RE, Tector J, Brems JJ, Li AP, Kaminski DL. Sulfation and glucuronidation of acetaminophen by cultured hepatocytes replicating in vivo metabolism. ASAIO Transactions. 1990;36:607–610.

    Google Scholar 

  15. Surh YJ, Liem A, Miller EC, Miller JA. Age-and sex-related differences in activation of the carcinogen 7-hydroxymethyl-12-methylbenz[a]anthracene to an electrophilic sulfuric acid ester metabolite in rats. Biochem Pharmacol. 1991;41:213–221.

    CAS  PubMed  Article  Google Scholar 

  16. Nakagomi M, Suzuki E, Kitashima M, et al. Sex difference in the metabolism of pirmenol in rats. Biol Pharm Bull. 1997;20:1279–1284.

    CAS  PubMed  Article  Google Scholar 

  17. Rao UN, Aravindakshan M, Satyanarayan V, Chauhan PS. Genotype-and gender-dependent hepatic alcohol dehydrogenase (ADH) activity in developing mice. http://www.ncbi.nlm.nih.gov/htbin-post/PubMed/wgetcit?journal=Alcohol&volume=14&page=527&display=abstract&format=htmlAlcohol. 1997;14:527–531.

    CAS  Google Scholar 

  18. Urakami Y, Nakamura N, Takahasi K, et al. Gender differences in expression of organic cation transporter OCT2 in rat kidney. FEBS Letters. 1999;461:339–342.

    CAS  PubMed  Article  Google Scholar 

  19. Bradley G, Georges E, Ling V. Sex-dependent and independent expression of the P-glycoprotein isoforms in Chinese hamster. J Cell Physiol. 1990;145:398–408.

    CAS  PubMed  Article  Google Scholar 

  20. Grubb BR, Boucher RC. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev. 1999;79:193–214.

    Google Scholar 

  21. McPhail ME, Knowles RG, Salter M, Dawson J, Burchell B, Pogson CI. Uptake of acetaminophen (Paracetamol) by isolated rat liver cells. Biochem Pharmacol. 1993;45:1599–1604.

    CAS  PubMed  Article  Google Scholar 

  22. Miyazaki K, Takemoto C, Satoh T, Ueno K, Igarashi T, Kitagawa H. Toxicity and biotransformation of acetaminophen in rat hepatocytes (I). Uptake and release. Res Comm Chem Pathol Pharmacol. 1983;39:77–86.

    CAS  Google Scholar 

  23. Slattery JT, McRone TI, Reynolds R, Kalhorn TF, Kharasch ED, Eddy C. Lack of effect of cimetidine on acetaminophen disposition in humans. Clin Pharmacol. 1989;46:591–597.

    CAS  Google Scholar 

  24. Slattery JT, Wilson JM, Kalhorn TF, Nelson SD. Dose-dependent pharmacokinetics of acetaminophen: evidence of glutathione depletion in humans. Clin Pharmacol Ther. 1987;41:413–418.

    CAS  PubMed  Article  Google Scholar 

  25. Hjelle JJ. Hepatic UDP-glucuronic acid regulation during acetaminophen biotransformation in rats. J Pharmacol Ther. 1986;237:750–756.

    CAS  Google Scholar 

  26. Radi R, Tan S, Prodanov E, Evans RA, Parks DA. Inhibition of xanthine oxidase by uric acid and its influence on superoxide radical production. Biochimica et Biophysica Acta. 1992;1122:178–182.

    CAS  PubMed  Article  Google Scholar 

  27. Milne ML, Baran DT. End product inhibition of hepatic 25-hydroxyvitamin D production in the rat: apecificity and kinetics. Arch Biochem Biophys 1985;242:488–492.

    CAS  PubMed  Article  Google Scholar 

  28. Wang LH, Rudolph AM, Benet LZ. Comparative study of acetaminophen disposition in sheep at three developmental stages, the fetal, neonatal, and adult periods. Devel Pharmacol Ther. 1990;14:161–179.

    CAS  Google Scholar 

  29. Trezise AEO, Ratcliff R, Hawkins TE, et al. Co-ordinate regulation of the cystic fibrosis and multidrug resistance genes in cystic fibrosis knockout mice. Hum Mol Genetics. 1997;6:527–537.

    CAS  Article  Google Scholar 

  30. Trezise AEO, Romano PR, Gill DR, et al. The multidrug resistance and cystic fibrosis genes have complementary patterns of epithelial expression. EMBO J. 1992;11:4291–4303.

    CAS  PubMed Central  PubMed  Google Scholar 

  31. Johannesson M, Nordqvist AS, Bogdanovic N, Hjelte L, Schalling M. Polymorphic expression of multidrug resistance mRNA in lung parenchyma of nonpregnant and pregnant rats. A comparison to cystic fibrosis mRNA expression. Biochem Biophy. Res Comm. 1997;239:606–611.

    CAS  Article  Google Scholar 

  32. Boxenbaum H. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance extrapolation of data to benzodiazepines and phenytom. J Pharmacokin Biopharm. 1980;8:165–176.

    CAS  Article  Google Scholar 

  33. O’Sullivan TA, Bauer LA, Horn JR, et al. Disposition of drugs in cystic fibrosis. II. Hepatic blood flow. Clin Pharmacol Ther. 1991;50:450–455.

    PubMed  Article  Google Scholar 

Download references

Author information

Affiliations

  1. Wake Forest University Medical Center, Winston Salem, North Carolina, USA

    Swarupa G. Kulkarni & Anita A. Pegram

  2. Division of Drug Delivery and Disposition, School of Pharmacy, University of North Carolina-Chapel Hill, 27599, Chapel Hill, North Carolina, USA

    Philip C. Smith

Authors
  1. Swarupa G. Kulkarni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anita A. Pegram
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philip C. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Philip C. Smith.

Additional information

published June 22, 2000

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kulkarni, S.G., Pegram, A.A. & Smith, P.C. Disposition of acetaminophen and indocyanine green in cystic fibrosis-knockout mice. AAPS PharmSci 2, 109–116 (2000). https://doi.org/10.1208/ps020218

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/ps020218

Keywords

  • Cystic Fibrosis
  • Cystic Fibrosis Patient
  • APAP
  • Indocyanine Green
  • Hepatic Blood Flow